Market Scenario:
Eye diseases in diabetic patients are known as diabetic retinopathy. High
blood sugar levels lead to the damage of the blood vessels in the retina. This
results in the swelling and leakage of blood vessels or the blood vessels may
close, thereby stopping blood from passing through. Sometimes, abnormal growth
of new blood vessels is found on the retina. Blurred vision, dark or empty
areas in your vision, spots or dark strings floating in the vision (floaters),
impaired color vision, and vision loss are various symptoms of diabetic
retinopathy. Vitreous hemorrhage, retinal detachment, glaucoma, and blindness
are various complications associated with diabetic retinopathy, which may
further lead to vision loss. The disease can be prevented by managing diabetes,
controlling blood glucose levels, attention to vision changes, and many other
methods in order to avoid vision impairment or vision loss.
The
global diabetic retinopathy market is driven by the increasing prevalence of
diabetes, rising awareness about diabetic retinopathy, and availability of
treatment in the market. Furthermore, the increasing demand for diagnostic
tests for the early diagnosis of diabetic retinopathy drives the growth of the
market. However, the growth of the market is restrained by inaccuracy in a
diagnostic test and lack of awareness about diagnosis and treatment of the
diseases among the geriatric population, especially in developing countries
across the globe.
Diabetic
Retinopathy Market is expected to grow at a CAGR of 5.2% during the forecast
period.
Segments
The global diabetic retinopathy
market is segmented on the basis of type, diagnosis, treatment, indication, and
end-user.
On the basis of type, the market
is segmented into non-proliferative diabetic retinopathy and proliferative
advanced diabetic retinopathy.
On the basis of diagnosis, the
market is segmented into fluorescein angiography and optical coherence
tomography.
On the basis of treatment, the
market is segmented into laser treatment, anti-VEGF Therapy, vitrectomy, and
others. The laser treatment is further segmented into focal laser treatment and
scatter laser treatment.
On the basis of end-user, the
market is segmented into hospitals and clinics, diagnostic centers, research
institutes, and others.
Regional Analysis of the Global
Diabetic Retinopathy Market
The American diabetic retinopathy
is the largest across the globe and is driven by the diagnostic imaging and
increasing focus on early diagnosis of diseases. The U.S. is the largest market
in North America which is driven by the increasing number of diabetic patients
becoming aware of the diagnosis and treatment of diabetic retinopathy and the
increasing demand for diagnostic tests in hospitals and clinics. Further,
people in Americas are now getting aware of the prevention of the disease
thereby avoiding further complications. The presence of major players and
emphasis on preventive care also stimulate the growth of the market. Canada is
expected to be the fastest growing market with the increasing number of
diagnostic and treatment services. South America also exhibits tremendous
growth opportunities in the market.
The European diabetic retinopathy
market is driven by the increasing patient population and availability of
treatment options for diabetes. Furthermore, the increasing emphasis on
diabetes management and the rising importance of early diagnosis and treatment
of the disease among the general population are also expected to fuel the
growth of the market during the forecast period. The growth of the market in
Germany, the largest contributor to the market growth, is driven by huge
investments in research and development on lifestyle diseases such as diabetes,
cardiovascular diseases, obesity, and others.
In Asia Pacific, the market
growth is boosted by various factors such as high prevalence of chronic
diseases such as obesity, diabetes, and others and presence of a huge geriatric
population in countries such as China. Furthermore, the diabetic population in
China and India has created a demand for diagnosis and treatment of diabetic
retinopathy, thereby accelerating the market growth. Other factors affecting
the growth of the market in Asia Pacific are lifestyle changes, obesity, and
sedentary lifestyle of people.
The market in the Middle East and
Africa determines a steady growth with the increasing demand for diabetes
management and rising number of diagnostic services. Saudi Arabia and the
United Arab Emirates (U.A.E.) are the largest contributors to the growth of the
market in the Middle East.
Key Players in the Global
Diabetic Retinopathy Market
Some of the key players in this
market are Novartis AG (Germany), Bayer (Germany), Regeneron Pharmaceuticals
Inc. (U.S.), ThromboGenics (U.S.), Actavis Plc (U.K.), Sirnaomics (U.S.),
Genentech (U.S.), Alimera Sciences (U.S.), Glycadia Pharmaceuticals (U.S.),
Ampio Pharmaceuticals (U.S.), Kowa Group (Japan), BCN Peptides (Spain), and
others.
Browse
Complete 100 Pages Premium Research Report Enabled with Respective Tables and
Figures @ https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792
Table of Content
1.
Report Prologue
2.
Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2 Assumptions
2.2.3
Limitations
3.
Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
4.
Market Dynamics
4.1
Drivers
4.2
Restraints
4.3
Opportunities
4.4
Challenges
4.5
Macroeconomic Indicators
4.6 Technology
Trends & Assessment
5. Market Factor Analysis
5.1
Porter’s Five Forces Analysis
5.1.1
Bargaining Power Of Suppliers
5.1.2
Bargaining Power Of Buyers
5.1.3
Threat Of New Entrants
5.1.4
Threat Of Substitutes
5.1.5
Intensity Of Rivalry
5.2
Value Chain Analysis
5.3
Investment Feasibility Analysis
5.4
Pricing Analysis
…Continued!
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment